SERS immunoassay for detection of procalcitonion in serum from patients with premature rupture of membranes using hollow Au nanocages and Ag nanowires-decorated filter paper.

Procalcitonion (PCT) have been proved to be disease-related markers of premature rupture of membranes (PROM) in serum of patients. Therefore, the profiling technology of rapid and sensitive is crucial for detecting the level of PCT in human serum, which is of great significance for early diagnosis and treatment of PROM. In this work, the surface-enhanced Raman scattering (SERS) detection platform combined with double antibody sandwich method was used to quantitatively detect PCT in serum of patients with PROM. A highly sensitive, uniform, and reliable SERS substrate was fabricated by assembling Ag nanowires (AgNWs) on the hydrophobic filter paper treated with alkyl ketene dimer (AKD). Then hollow Au nanocages (HAuNCs) with SERS activity were synthesized facilely. The SERS immunoassay system consists of SERS tags and capturing substrate. HAuNCs labled anti-PCT (labeling) were used as SERS tags. Filter paper modified with AgNWs and anti-PCT (coating) was used as capturing substrate. When the SERS immunoassay system were used to directly detect PCT antigen, Raman intensity at different PCT antigen concentrations (1 pg/mL-1 μg/mL) was linearly related to the logarithm of PCT antigen concentration. By establishing a calibration curve within a certain range, it can be concluded that the detection limits of PBS and human serum were as low as 2.86 pg/mL and 3.74 pg/mL respectively. Serum samples from PROM patients were detected by SERS, and the results were consistent with those of the enzyme-linked immunosorbent assay (ELISA). Furthermore, The high reproducibility and homogeneity of SERS immunoassay were confirmed. Above results demonstrated the feasibility and great potential for developing this new SERS immunosensor into a clinical tool for sensitive analysis of biomarkers in human serum. [ABSTRACT FROM AUTHOR]